Phillip Md Et Al Frost Purchases 200,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
Phillip Md Et Al Frost Purchases 200,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK – Get Rating) CEO Phillip Md Et Al Frost bought 200,000 shares of the firm's stock in a transaction dated Thursday, September 15th. The shares were acquired at an average price of $2.06 per share, for a total transaction of $412,000.00. Following the completion of the transaction, the chief executive officer now owns 197,456,694 shares in the company, valued at approximately $406,760,789.64. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
奧普科健康公司(納斯達克代碼:OPK-GET Rating)首席執行官菲利普·馬德等·弗羅斯特在9月15日星期四的交易中購買了該公司20萬股股票。這些股票是以每股2.06美元的平均價格收購的,總交易額為412,000.00美元。交易完成後,首席執行官現在擁有該公司197,456,694股,價值約406,760,789.64美元。此次收購是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過美國證券交易委員會網站訪問。
Phillip Md Et Al Frost also recently made the following trade(s):
菲利普·馬德和阿爾·弗羅斯特最近還進行了以下交易:
- On Wednesday, August 17th, Phillip Md Et Al Frost bought 200,000 shares of OPKO Health stock. The shares were acquired at an average price of $2.54 per share, for a total transaction of $508,000.00.
- On Friday, August 5th, Phillip Md Et Al Frost bought 350,000 shares of OPKO Health stock. The shares were acquired at an average price of $2.29 per share, for a total transaction of $801,500.00.
- On Tuesday, June 21st, Phillip Md Et Al Frost purchased 200,000 shares of OPKO Health stock. The stock was purchased at an average price of $2.39 per share, for a total transaction of $478,000.00.
- 8月17日,星期三,Phillip Md et Al Frost購買了20萬股OPKO Health股票。這些股票是以每股2.54美元的平均價格收購的,總交易額為508,000.00美元。
- 8月5日,星期五,Phillip Md et Al Frost購買了35萬股OPKO Health股票。這些股票是以每股2.29美元的平均價格收購的,總交易額為801,500.00美元。
- 6月21日,星期二,Phillip Md et Al Frost購買了20萬股OPKO Health股票。股票是以每股2.39美元的平均價格購買的,總交易額為478,000.00美元。
OPKO Health Price Performance
Opko健康性價比
NASDAQ:OPK opened at $2.05 on Friday. The firm has a market cap of $1.58 billion, a PE ratio of -7.07 and a beta of 1.75. OPKO Health, Inc. has a 12 month low of $1.96 and a 12 month high of $5.25. The company has a quick ratio of 1.91, a current ratio of 2.30 and a debt-to-equity ratio of 0.12. The company's 50-day moving average price is $2.42 and its two-hundred day moving average price is $2.81.
納斯達克:OPK上週五開盤報2.05美元。該公司的市值為15.8億美元,市盈率為-7.07倍,貝塔係數為1.75。Opko Health,Inc.的12個月低點為1.96美元,12個月高位為5.25美元。該公司的速動比率為1.91,流動比率為2.30,債務權益比率為0.12。該公司的50日移動均線價格為2.42美元,200日移動均線價格為2.81美元。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
Separately, Piper Sandler reduced their price target on shares of OPKO Health from $5.00 to $4.00 and set an "overweight" rating on the stock in a research report on Friday, August 5th.
另外,派珀·桑德勒將OPKO Health的股票目標價從5.00美元下調至4.00美元,並在8月5日星期五的一份研究報告中對該股設定了“增持”評級。
Hedge Funds Weigh In On OPKO Health
對衝基金對OPKO健康的看法
Large investors have recently modified their holdings of the stock. Swiss National Bank lifted its position in shares of OPKO Health by 7.5% during the first quarter. Swiss National Bank now owns 1,047,200 shares of the biotechnology company's stock worth $3,602,000 after purchasing an additional 72,900 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of OPKO Health by 19.2% during the fourth quarter. BNP Paribas Arbitrage SA now owns 165,928 shares of the biotechnology company's stock worth $798,000 after purchasing an additional 26,707 shares in the last quarter. Columbia Asset Management acquired a new position in shares of OPKO Health during the fourth quarter worth approximately $67,000. E Fund Management Co. Ltd. lifted its position in shares of OPKO Health by 190.1% during the first quarter. E Fund Management Co. Ltd. now owns 81,338 shares of the biotechnology company's stock worth $280,000 after purchasing an additional 53,299 shares in the last quarter. Finally, Levin Capital Strategies L.P. acquired a new position in shares of OPKO Health during the first quarter worth approximately $52,000. 27.83% of the stock is currently owned by institutional investors and hedge funds.
大型投資者最近調整了對該股的持有量。瑞士國家銀行在第一季度將其在OPKO Health的股票頭寸提高了7.5%。瑞士國家銀行目前持有這家生物技術公司的1,047,200股股票,價值3,602,000美元,上個季度又購買了72,900股。法國巴黎銀行套利公司在第四季度將其在OPKO Health股票的頭寸提高了19.2%。法國巴黎銀行套利公司現在持有這家生物技術公司的165,928股股票,價值79.8萬美元,上個季度又購買了26,707股。哥倫比亞資產管理公司在第四季度收購了OPKO Health的新頭寸,價值約6.7萬美元。易方達基金管理有限公司在第一季度將其在OPKO Health的股票頭寸提高了190.1%。E Fund Management Co.Ltd.在上個季度增購了53,299股後,現在持有這家生物技術公司81,338股股票,價值28萬美元。最後,Levin Capital Strategy L.P.在第一季度收購了OPKO Health公司價值約5.2萬美元的新頭寸。該公司27.83%的股票目前由機構投資者和對衝基金持有。
OPKO Health Company Profile
Opko Health公司簡介
(Get Rating)
(獲取評級)
OPKO Health, Inc, a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services.
Opko Health,Inc.是一家醫療保健公司,在美國、愛爾蘭、智利、西班牙、以色列、墨西哥和國際上從事診斷和製藥業務。該公司的診斷部門經營着BioReference實驗室,該實驗室為疾病的檢測、診斷、評估、監測和治療提供實驗室測試服務,包括深奧測試、分子診斷、解剖病理學、遺傳學、婦女健康以及為醫生辦公室、診所、醫院、僱主和政府單位提供的矯正保健;以及在護理地點提供血液測試結果的新型診斷儀器系統,以及4KScore前列腺癌測試服務。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on OPKO Health (OPK)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
- 免費獲取StockNews.com關於OPKO健康的研究報告(OPK)
- 第四季度值得考慮的3家銀行
- 股市:紅海中的三座強國
- MarketBeat:回顧一週9/12-9/16
- 有什麼辦法可以治癒Teladoc股票的問題嗎?
- 沒有人告訴這三隻股票這是下跌的一週
Receive News & Ratings for OPKO Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OPKO Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受OPKO健康日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對OPKO Health和相關公司的最新新聞和分析師評級的每日簡要摘要。